DE60135486D1 - Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung - Google Patents

Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung

Info

Publication number
DE60135486D1
DE60135486D1 DE60135486T DE60135486T DE60135486D1 DE 60135486 D1 DE60135486 D1 DE 60135486D1 DE 60135486 T DE60135486 T DE 60135486T DE 60135486 T DE60135486 T DE 60135486T DE 60135486 D1 DE60135486 D1 DE 60135486D1
Authority
DE
Germany
Prior art keywords
drug
composition
compositions
production
delayed delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60135486T
Other languages
English (en)
Inventor
Min-Hyo Seo
Yil-Woong Yi
Sang-Jun Lee
Jae-Hong Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samyang Biopharmaceuticals Corp
Original Assignee
Samyang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Corp filed Critical Samyang Corp
Application granted granted Critical
Publication of DE60135486D1 publication Critical patent/DE60135486D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Steroid Compounds (AREA)
DE60135486T 2000-12-07 2001-12-07 Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung Expired - Lifetime DE60135486D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20000074098 2000-12-07
PCT/KR2001/002121 WO2002045689A1 (en) 2000-12-07 2001-12-07 Compositions for sustained delivery of hydrophobic drugs and process for the preparation thereof

Publications (1)

Publication Number Publication Date
DE60135486D1 true DE60135486D1 (de) 2008-10-02

Family

ID=19702771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135486T Expired - Lifetime DE60135486D1 (de) 2000-12-07 2001-12-07 Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung

Country Status (10)

Country Link
US (1) US7153520B2 (de)
EP (1) EP1339389B1 (de)
JP (1) JP2004514734A (de)
KR (1) KR100446101B1 (de)
CN (1) CN1234416C (de)
AT (1) ATE405251T1 (de)
AU (2) AU2002222733B2 (de)
CA (1) CA2430481C (de)
DE (1) DE60135486D1 (de)
WO (1) WO2002045689A1 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2003017987A1 (en) * 2001-08-31 2003-03-06 Mcgill University Biodegradable polymeric nanocapsules and uses thereof
MXPA04003621A (es) * 2001-10-18 2004-07-30 Samyang Corp Composicion de micela polimerica con estabilidad mejorada.
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
NZ537953A (en) 2002-07-31 2007-02-23 Alza Corp Injectable multimodal polymer depot compositions and uses thereof
AU2003272284B2 (en) * 2002-09-05 2009-03-05 Catherine G. Ambrose Antibiotic microspheres for treatment of infections and osteomyelitis
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
EP1555984B1 (de) * 2002-10-21 2008-03-12 L'oreal Verfahren zum auflösen lipophiler verbindungen, und kosmetische zusammensetzung.
EP1627645B1 (de) * 2003-05-26 2017-08-23 Hiroshi Maeda Antitumorales mittel und verfahren zu seiner herstellung
EP1635875B8 (de) * 2003-06-26 2008-12-24 pSivida Inc In-situ gelierendes arzneimittelabgabesystem
WO2005000268A2 (en) 2003-06-26 2005-01-06 Control Delivery Systems, Inc. Bioerodible sustained release drug delivery systems
KR101054728B1 (ko) 2004-06-16 2011-08-05 (주)아모레퍼시픽 난용성 발모 및 육모 생리활성 물질인 사이클로스포린을포함하는 나노입자 및 이를 함유하는 피부 외용제 조성물
JP4939936B2 (ja) * 2003-06-27 2012-05-30 株式會社アモーレパシフィック 生理活性成分を含有する自己集合性高分子ナノ粒子の製造方法、及び得られた自己集合性高分子ナノ粒子を含有する外用剤組成物
WO2005000258A1 (en) * 2003-06-27 2005-01-06 Amorepacific Corporation Self-assembled polymeric nanoparticles containing physiologically active ingredients and external application containing the nanoparticles
KR100967113B1 (ko) 2003-12-03 2010-07-05 (주)아모레퍼시픽 코엔자임 ｑ10을 함유한 자기회합성 고분자 나노입자 및이를 함유한 피부 외용제 조성물
KR20050064075A (ko) * 2003-12-23 2005-06-29 주식회사 삼양사 이트라코나졸을 유효성분으로 하는 약학적 조성물
GB0412866D0 (en) * 2004-06-09 2004-07-14 Novartis Ag Organic compounds
US8980300B2 (en) 2004-08-05 2015-03-17 Advanced Cardiovascular Systems, Inc. Plasticizers for coating compositions
US20060034889A1 (en) * 2004-08-16 2006-02-16 Macromed, Inc. Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
EP1827395A2 (de) 2004-11-02 2007-09-05 Tel-Aviv University Future Technology Development L.P. Formulierungen von wasserunlöslichen oder schwer wasserlöslichen arzneimitteln in lipidierten glykosaminoglykanpartikeln, deren herstellung und deren verwendung zur diagnose und therapie
NZ556290A (en) * 2005-01-04 2010-11-26 Intezyne Technologies Inc Synthesis of hybrid block copolymers and uses thereof
JP2007023023A (ja) * 2005-06-15 2007-02-01 Kanagawa Acad Of Sci & Technol 組織接着性薬剤放出ゲル形成用組成物
US20090306339A1 (en) * 2006-09-19 2009-12-10 Van Boxtel Huibert Albertus Preparation of Fine Particles
EP2081548A2 (de) * 2006-09-22 2009-07-29 Labopharm Inc. Zusammensetzungen und verfahren für die ph-gezielte arzneiabgabe
CA2663558C (en) * 2006-09-26 2013-05-28 Samyang Corporation Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
GB0714223D0 (en) * 2007-07-20 2007-08-29 Fujifilm Mfg Europe Bv Preparation of fine particles
GB0720716D0 (en) * 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
US8642062B2 (en) * 2007-10-31 2014-02-04 Abbott Cardiovascular Systems Inc. Implantable device having a slow dissolving polymer
US9090737B2 (en) 2007-11-13 2015-07-28 Surmodics, Inc. Viscous terpolymers as drug delivery platform
US9801818B2 (en) 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
JP5576291B2 (ja) * 2007-12-31 2014-08-20 サムヤン バイオファーマシューティカルズ コーポレイション ポリ（α−ヒドロキシ酸）の疎水性高分子ブロックを含む高純度の両親媒性ブロック共重合体及びその製造方法
CN101909601B (zh) * 2008-01-18 2013-06-26 陶氏环球技术公司 使用甲氧基聚乙二醇增强难溶性活性剂的水溶解度的方法
US8431161B2 (en) 2008-02-22 2013-04-30 Toray Industries, Inc. Microparticle and pharmaceutical composition thereof
US8858995B2 (en) * 2008-03-10 2014-10-14 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
EP2103313A1 (de) * 2008-03-19 2009-09-23 Koninklijke Philips Electronics N.V. Verfahren für die Synthese von Hohlkugeln
TWI388591B (zh) * 2008-03-28 2013-03-11 Ind Tech Res Inst 溫度敏感性材料
US8916188B2 (en) 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
EP2309991B1 (de) 2008-06-16 2019-03-06 Pfizer Inc Therapeutische polymernanopartikel mit vincaalkaloiden sowie verfahren zu ihrer herstellung und verwendung
US8613951B2 (en) 2008-06-16 2013-12-24 Bind Therapeutics, Inc. Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
PT2774608T (pt) 2008-06-16 2020-01-17 Pfizer Nanopartículas poliméricas carregadas com fármaco e métodos de produção e utilização das mesmas
EP2172189A1 (de) * 2008-10-01 2010-04-07 Novartis AG Pharmazeutische Zusammensetzungen
ES2600797T3 (es) 2008-08-12 2017-02-10 Novartis Ag Composiciones farmacéuticas
JP2010065067A (ja) * 2008-09-08 2010-03-25 Tokyo Univ Of Agriculture & Technology 粒子およびその製造方法、ならびにゲル
EP2346515A4 (de) * 2008-09-25 2013-01-23 Invivo Therapeutics Corp Rückenmarksläsion, entzündung und immunerkrankung: lokale gesteuerte freisetzung von therapeutika
TWI372057B (en) * 2008-12-11 2012-09-11 Dev Center Biotechnology Sustained release implant for granisetron
CN102292076A (zh) * 2008-12-11 2011-12-21 阿帕医药有限公司 增强聚原酸酯及其制剂的稳定性的方法
JP2012512175A (ja) 2008-12-15 2012-05-31 バインド バイオサイエンシズ インコーポレイテッド 治療薬を徐放するための長時間循環性ナノ粒子
US9480643B2 (en) * 2008-12-23 2016-11-01 Surmodics Pharmaceuticals, Inc. Implantable composites and implants comprising same
US20100158978A1 (en) * 2008-12-23 2010-06-24 Peter Markland Bioactive spray coating compositions and methods of making and uses thereof
US8974808B2 (en) * 2008-12-23 2015-03-10 Surmodics, Inc. Elastic implantable composites and implants comprising same
US9415197B2 (en) 2008-12-23 2016-08-16 Surmodics, Inc. Implantable suction cup composites and implants comprising same
US8951546B2 (en) 2008-12-23 2015-02-10 Surmodics Pharmaceuticals, Inc. Flexible implantable composites and implants comprising same
EP2201935B1 (de) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymere Mizellenzusammensetzung, die ein schlecht lösliches Arzneimittel enthält, und zugehöriges Herstellungsverfahren
TWI374903B (en) * 2008-12-31 2012-10-21 Ind Tech Res Inst Biodegradable copolymer hydrogel materials
US20100203150A1 (en) * 2009-02-06 2010-08-12 National Tsing Hua University Novel amphiphilic copolymers and fabrication method thereof
WO2010114768A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-epothilone conjugates, particles, compositions, and related methods of use
EP2413901A4 (de) * 2009-03-30 2015-05-06 Cerulean Pharma Inc Polymerstoffkonjugate, partikel, zusammensetzungen und entsprechende verwendungsverfahren
SI3403654T1 (sl) 2009-10-01 2019-10-30 Adare Dev I L P Oralno administrirani kortikosteroidni sestavki
JP5891175B2 (ja) 2009-12-11 2016-03-22 バインド セラピューティックス インコーポレイテッド 治療用粒子の凍結乾燥に対する安定製剤
US9295649B2 (en) 2009-12-15 2016-03-29 Bind Therapeutics, Inc. Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
WO2011119995A2 (en) 2010-03-26 2011-09-29 Cerulean Pharma Inc. Formulations and methods of use
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
US9598532B2 (en) 2010-08-30 2017-03-21 Surmodics, Inc. Terpolymers as pressure-sensitive adhesives
NZ612326A (en) 2010-12-29 2014-10-31 Medincell Biodegradable drug delivery compositions
WO2012177825A1 (en) 2011-06-21 2012-12-27 Bvw Holding Ag Medical device comprising boswellic acid
WO2013148682A1 (en) * 2012-03-26 2013-10-03 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
EP2866837B1 (de) * 2012-06-27 2022-12-14 Medincell S.A. Biologisch abbaubare wirkstofffreisetzung für hydrophobe zusammensetzungen
EP2895156B1 (de) 2012-09-17 2019-05-08 Pfizer Inc. Verfahren zur herstellung therapeutischer nanopartikel
US20150104520A1 (en) * 2013-04-05 2015-04-16 Vuong Trieu Nanoparticle Formulations in Biomarker Detection
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104761710B (zh) * 2014-02-14 2016-06-29 苏州海特比奥生物技术有限公司 一种聚乙二醇单甲醚-聚乳酸嵌段共聚物及其制备方法
ME03435B (de) 2014-03-14 2020-01-20 Pfizer Therapeutische nanopartikel mit einem behandlungsmittel sowie verfahren zur herstellung und verwendung davon
AU2016280274B2 (en) * 2015-06-18 2021-12-02 Acuitybio Corporation Implantable drug delivery compositions and methods of use thereof
LT3377041T (lt) 2015-11-16 2023-12-27 Medincell S.A. Farmaciškai aktyvių komponentų suskaidymo ir (arba) nukreipimo į sinovinį audinį būdas
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CN106727306A (zh) * 2016-12-12 2017-05-31 温州医科大学 一种高载药量曲安奈德胶束的制备方法
CN107596380B (zh) * 2017-09-03 2020-09-11 河南师范大学 基于聚乙二醇-聚碳酸酯的还原敏感性喜树碱前药及其制备方法和应用
KR102072419B1 (ko) * 2018-04-19 2020-02-03 중앙대학교 산학협력단 항암제 봉입 마이셀 제제 조성물
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
BR112022020991A2 (pt) * 2020-08-31 2023-03-07 Vaim Co Ltd Dispersão de polímero biodegradável, composição compreendendo a mesma e sistema de melhoria da pele
CN114903904B (zh) * 2021-02-08 2024-02-09 宜昌人福药业有限责任公司 瑞马唑仑药用盐和阿片样物质的注射用药物组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0474098B1 (de) * 1990-08-30 1994-03-02 Senju Pharmaceutical Co., Ltd. Zusammensetzung zur kontrollierten Abgabe von Medikamenten
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
JPH08176016A (ja) * 1994-12-19 1996-07-09 Univ Miami 生分解可能で注射可能な薬物運搬ポリマー
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US6004573A (en) 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US20020164374A1 (en) * 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof
KR100289074B1 (ko) * 1998-02-04 2001-07-12 김윤 난용성약물함유시스템
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
KR100274842B1 (ko) * 1998-10-01 2001-03-02 김효근 미립구를 이용한 레티노익산의 서방형 약물방출 시스템
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
WO2001085216A1 (en) * 2000-05-12 2001-11-15 Samyang Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof

Also Published As

Publication number Publication date
EP1339389B1 (de) 2008-08-20
US7153520B2 (en) 2006-12-26
AU2002222733B2 (en) 2006-03-30
KR100446101B1 (ko) 2004-08-30
WO2002045689A1 (en) 2002-06-13
CA2430481A1 (en) 2002-06-13
CN1234416C (zh) 2006-01-04
CA2430481C (en) 2008-07-22
AU2273302A (en) 2002-06-18
EP1339389A4 (de) 2007-08-08
ATE405251T1 (de) 2008-09-15
US20040037885A1 (en) 2004-02-26
JP2004514734A (ja) 2004-05-20
CN1477952A (zh) 2004-02-25
KR20020045569A (ko) 2002-06-19
EP1339389A1 (de) 2003-09-03

Similar Documents

Publication Publication Date Title
DE60135486D1 (de) Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung
WO2004112748A3 (en) Rate controlled release of a pharmaceutical agent in a biodegradable device
DE60031286D1 (de) Polymere zusammensetzung zur lösung von schwer wasserlöslichen medikamenten und verfahren zu deren herstellung
EP0863933B1 (de) Hydrogele auf basis von dreiblockcopolymerisate, ihre herstellung und ihre verwendung
ATE141788T1 (de) Mikrosphäre enthaltende pharmazeutische zusammensetzung mit kontrollierter freigabe und verfahren zur herstellung
WO2001091725A3 (en) Biologically useful polyphosphates
ATE468848T1 (de) In organischen lösemitteln lösliche biologisch abbaubare poly (alkylenoxid)- poly (p-dioxanon) blockcopolymere sowie diese enthaltende zusammensetzung zur arzneistoffverabreichung
CA2451187A1 (en) Zero-order prolonged release coaxial implants
CA2395077A1 (en) Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
CA2452806A1 (en) Water-soluble stabilized self-assembled polyelectrolytes
BRPI0510568A (pt) copolìmero, processo para preparação do mesmo, partìcula biodegradável, uso da mesma, processo para preparação de um sistema de liberação, composição para perfumar, e, produto perfumado
ATE313586T1 (de) Mehrarmige blockcopolymere und pharmazeutische zusammensetzung
DK1521572T3 (da) Biologisk nedbrydelig film til indförsel af öjenlægemiddel
EP2219608B1 (de) Selbstverfestigendes bioerodierbares barriereimplantat
PT1126822E (pt) Composicoes de libertacao liquida controlada com baixa libertacao inicial da droga
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
KR20140016233A (ko) 지혈 발포체 이식물의 제자리 형성
EP1183538A4 (de) Zyklodexrinpolymere zum gebrauch als medikamententräger
WO2004032862A3 (en) Cyclodextrin-based materials, compositions and uses related thereto
BRPI0410956A (pt) pelìculas com base em óxido de polietileno e sistemas de liberação de droga feitos delas
JP2008540725A (ja) 水素結合ヒドロゲル
EP1539109B1 (de) Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung
EA027046B1 (ru) Биоразлагаемая композиция для доставки лекарственных средств, способ ее получения и ее применение
WO2003037337A8 (en) Depot formulations of iloperidone and a star polymer
Overstreet et al. In situ forming, resorbable graft copolymer hydrogels providing controlled drug release

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1339389

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

R081 Change of applicant/patentee

Ref document number: 1339389

Country of ref document: EP

Owner name: SAMYANG BIOPHARMACEUTICALS CORP., KR

Free format text: FORMER OWNER: SAMYANG CORP., SEOUL/SOUL, KR

Effective date: 20120813

R082 Change of representative

Ref document number: 1339389

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

Effective date: 20120813